What are glioblastomas?
Call 314-362-3577 for Patient Appointments
Glioblastomas, categorized as World Health Organization Grade 4 tumors, are the most common malignant tumors that arise from the brain. This cancer does not typically spread to other parts of the body. Newly diagnosed or primary glioblastomas are tumors that have just been discovered whereas recurrent glioblastomas are ones that have come back after therapy.
Sometimes, gliomas (or glial tumors) of a lower grade can transform into glioblastomas, also known as secondary glioblastomas. New molecular characteristics about specific types of glioblastomas are becoming discovered all the time by investigators at Washington University and colleagues internationally, which can inform personalized treatment and clinical trial decisions.
Why rely on Washington University experts for brain tumor treatment?
Washington University neurosurgeons oversee one of the largest brain tumor clinical trial programs in the United States, performing more than 1000 brain tumor surgeries and other procedures annually.
We offer the latest clinical trials and offer the most advanced treatments for brain tumors.
Our multidisciplinary team includes neurosurgeons, medical oncologists, radiation oncologists, otolaryngologists, neuroradiologists, ophthalmologists, pathologists, and other specialists dedicated to the treatment of the full range of brain tumors.
Our understanding and treatment of glioblastomas is advancing all the time, and therefore, our neurosurgeons place a strong emphasis on surgical innovation and clinical trials to bring tomorrow’s treatments to glioblastoma patients today.
Patients undergoing treatment by our neurosurgeons have access to the most advanced therapeutic techniques, such as surgery, innovative minimally invasive procedures, precision medicine, radiation therapy, chemotherapy, or a combination of these treatments.
Some of the advanced technologies and procedures we use are: